Rhovac ApS Company
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Hørsholm, Hovedstaden, Denmark
Founded Date:
2008-01-01
Employees Number:
11-50
Investors Number:
1
Total Funding:
85000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-08-22
Last Funding Type:
Grant
Register and Claim Ownership